Huang Ying 4

What Happened
Huang Ying, CEO of Legend Biotech (LEGN), sold 5,566 ordinary shares on 2026-06-25 in an open-market/private sale for a total of approximately $82,265. The reported average price was $14.78 per ordinary share (weighted ADS-equivalent price $29.56). This sale was done to satisfy tax withholding obligations related to the vesting of restricted share units, so it is a routine, tax-related disposition rather than an outright investment decision.

Key Details

• Transaction date: 2026-06-25; Form 4 filed: 2026-06-29 (filed within the 2 business-day reporting window).
• Shares sold: 5,566 ordinary shares; reported average price: $14.78 per ordinary share; total proceeds ≈ $82,265.
• ADS conversion: Each ADS = 2 ordinary shares; sale equals 2,783 ADS with weighted ADS price $29.56. Reported ADS sale prices ranged $28.13–$29.98 (ordinary-share equivalent $14.065–$14.99).
• Footnotes: Sale was to satisfy withholding tax on RSU vesting (tax-withholding transaction). Full per-price breakdown available on request per the filing.
• Shares owned after transaction: Not specified in the provided filing.

Context
This was a tax-withholding sale tied to vested restricted share units (code F in filings), commonly seen after awards vest and generally not read as a directional signal about the executive’s view of the company. The transaction is reported as a sale (S) and was filed timely.